A team jointly led by Dr Alistair McEwan, an electrical and information technologies engineer at the university, and honorary Professor Heather Jeffery, a specialist in maternal and child health, is now conducting successful trials of the device in Soweto, Africa.
The unit developed by the team uses near infrared (NIR) to assess an infant’s body composition and is suitable for use in areas where there is limited electricity supply and technical expertise.
Dr McEwan said: “The portable and easy-to-use device uses light to measure the amount of fat under the skin so that infants don't need to be placed in a scanner or have a skin pinch test.
They say the device can be made inexpensively with only five sensors. Crucially, it does not require the length or height of the infant to be measured, avoiding the difficulty of children who wriggle and protest at being held flat.
“Light in the NIR range is used where our skin is transparent; this type of light is not visible to humans for example on a TV remote control, but can be sensed by nocturnal animals and snakes,” Dr McEwan added:
“NIR is a highly accurate technology that uses multiple wavelengths to separate a human’s body components such as temperature, melanin, water, dermis, muscle or fat under the skin.”
“The human skin is transparent in NIR light over a certain range of wavelengths. Our studies have shown that fat absorbs NIR and fat levels can be determined at five wavelengths.”
Professor Jeffery said low fat composition in newborns exposes them to an immediate risk of increased mortality and morbidity, and to diabetes and obesity diseases in later life.
“The lack of convenient, low-cost devices for monitoring nutrition has led to difficulties for health workers trying to identify malnourished infants, and in monitoring changes in the nutritional status of an infant who has received interventions,” she said.
The team, which also included Dr Angela Carberry, Dr Peter Jones and PhD candidates Jacqueline Huvanandana and Fatin Hamimi Mustafa, are now working alongside the University of Oxford’s INTERBIO-21st study to test their prototype device for suitability in different skin tones and in large communities in Africa.
The team’s work was support by Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges.